Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of Tuesday, October 6, 2026.
NET PROFIT MARGIN
N/A
Market Cap
$3.49M
Net Profit Margin
-105.71%
TTM Avg
-81.70%
3Y Avg
-1471.40%
5Y Avg
-1177.12%
Market Cap
$3.49M
Net Profit Margin
-4139.38%
TTM Avg
-3617.24%
3Y Avg
-2890.13%
5Y Avg
-2863.43%
Market Cap
$3.49M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.62M
Net Profit Margin
-694.19%
TTM Avg
-257.90%
3Y Avg
-726.73%
5Y Avg
-1357.15%
Market Cap
$3.59M
Net Profit Margin
0.00%
TTM Avg
-3826.38%
3Y Avg
-9879.36%
5Y Avg
-6586.24%
Market Cap
$3.64M
Net Profit Margin
-10.89%
TTM Avg
-10.89%
3Y Avg
-13.47%
5Y Avg
-4.61%
Market Cap
$3.60M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.32M
Net Profit Margin
-87.20%
TTM Avg
-5303.47%
3Y Avg
-2728.60%
5Y Avg
-1828.05%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.54M | N/A | N/A | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.49M | -105.71% | -81.70% | -1471.40% | -1177.12% |
| Nexalin Technology, Inc. (NXL)vs › | $3.49M | -4139.38% | -3617.24% | -2890.13% | -2863.43% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Evogene Ltd. (EVGN)vs › | $3.62M | -694.19% | -257.90% | -726.73% | -1357.15% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.59M | 0.00% | -3826.38% | -9879.36% | -6586.24% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.64M | -10.89% | -10.89% | -13.47% | -4.61% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.32M | -87.20% | -5303.47% | -2728.60% | -1828.05% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.83M | -730.23% | -1020.41% | -1573.84% | -1133.48% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
